Background: Establishing intravenous (IV) access is an essential procedure in surgical patients. External jugular vein (EJV) cannulation can be a good alternative for patients forwhom it is difficult to establish peripheral IV access. We aimed to investigate the feasibilityand safety of EJV cannulation in surgical patients.
Methods: We performed a retrospective review of EJV cannulation in patients who underwent anesthesia for surgery at a tertiary hospital between 2010 and 2021. We collectedclinical characteristics, including EJV cannulation-related variables, from the anesthetic records. We also investigated the EJV cannulation-related complications, which included anyEJV cannulation-related complications (insertion site swelling, infection, thrombophlebitis,pneumothorax, and arterial cannulation) within 7 days after surgery, from the electronicmedical records during the hospitalization period for surgery.
Results: We analyzed 9,482 cases of 9,062 patients for whom EJV cannulation was performed during anesthesia. The most commonly performed surgery was general surgery(49.6%), followed by urologic surgery (17.5%) and obstetric and gynecologic surgery (15.7%).Unplanned EJV cannulation was performed emergently during surgery for 878 (9.3%) cases.The only EJV cannulation-related complication was swelling at the EJV-cannula insertion site(65 cases, 0.7%). There was only one case of unplanned intensive care unit admission dueto swelling related to EJV cannulation.
Conclusions: Our study showed the feasibility and safety of EJV cannulation for surgical patients with difficult IV access or those who need additional large-bore IV access during surgery. EJV cannulation can provide safe and reliable IV access with a low risk of major complications in a surgical patient.
{"title":"Retrospective analysis of the feasibility and safety of external jugular vein cannulation in surgical patients.","authors":"Jae-Woo Ju, Yoonbin Hwang, Ho-Jin Lee","doi":"10.17085/apm.22171","DOIUrl":"https://doi.org/10.17085/apm.22171","url":null,"abstract":"<p><strong>Background: </strong>Establishing intravenous (IV) access is an essential procedure in surgical patients. External jugular vein (EJV) cannulation can be a good alternative for patients forwhom it is difficult to establish peripheral IV access. We aimed to investigate the feasibilityand safety of EJV cannulation in surgical patients.</p><p><strong>Methods: </strong>We performed a retrospective review of EJV cannulation in patients who underwent anesthesia for surgery at a tertiary hospital between 2010 and 2021. We collectedclinical characteristics, including EJV cannulation-related variables, from the anesthetic records. We also investigated the EJV cannulation-related complications, which included anyEJV cannulation-related complications (insertion site swelling, infection, thrombophlebitis,pneumothorax, and arterial cannulation) within 7 days after surgery, from the electronicmedical records during the hospitalization period for surgery.</p><p><strong>Results: </strong>We analyzed 9,482 cases of 9,062 patients for whom EJV cannulation was performed during anesthesia. The most commonly performed surgery was general surgery(49.6%), followed by urologic surgery (17.5%) and obstetric and gynecologic surgery (15.7%).Unplanned EJV cannulation was performed emergently during surgery for 878 (9.3%) cases.The only EJV cannulation-related complication was swelling at the EJV-cannula insertion site(65 cases, 0.7%). There was only one case of unplanned intensive care unit admission dueto swelling related to EJV cannulation.</p><p><strong>Conclusions: </strong>Our study showed the feasibility and safety of EJV cannulation for surgical patients with difficult IV access or those who need additional large-bore IV access during surgery. EJV cannulation can provide safe and reliable IV access with a low risk of major complications in a surgical patient.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"84-91"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/68/apm-22171.PMC9902628.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joonho Cho, Byung Hoon Yoo, Jihwan Park, Yun Hee Lim, In-Jung Jun, Kye-Min Kim
Background: The entanglement of multiple central venous catheters is a rare and seriouscomplication. The Swan-Ganz catheter is a responsible for various cases.
Case: A 66-year-old male patient was under general anesthesia for a coronary artery bypassgraft surgery. As he had a pre-existing Perm catheter in the right subclavian vein, a SwanGanz catheter was inserted into the left internal jugular vein. Chest radiograph after catheterplacement revealed that the Perm catheter had migrated to the left brachiocephalic vein.The surgeon attempted to reposition it manually, but postoperative radiograph showed thatit had rolled into a loop. On postoperative day 1, radiological intervention was performed tountangle the loop, which was successful.
Conclusions: After placing a Swan-Ganz catheter in patients with a pre-existing central venous catheter, the presence of entanglement should be assessed. In such cases, radiology-guided correction is recommended, as a blind attempt to disentangle can aggravate thecondition.
{"title":"Secondary migration of a pre-existing central venous catheter due to a Swan-Ganz catheter insertion - A case report.","authors":"Joonho Cho, Byung Hoon Yoo, Jihwan Park, Yun Hee Lim, In-Jung Jun, Kye-Min Kim","doi":"10.17085/apm.22212","DOIUrl":"https://doi.org/10.17085/apm.22212","url":null,"abstract":"<p><strong>Background: </strong>The entanglement of multiple central venous catheters is a rare and seriouscomplication. The Swan-Ganz catheter is a responsible for various cases.</p><p><strong>Case: </strong>A 66-year-old male patient was under general anesthesia for a coronary artery bypassgraft surgery. As he had a pre-existing Perm catheter in the right subclavian vein, a SwanGanz catheter was inserted into the left internal jugular vein. Chest radiograph after catheterplacement revealed that the Perm catheter had migrated to the left brachiocephalic vein.The surgeon attempted to reposition it manually, but postoperative radiograph showed thatit had rolled into a loop. On postoperative day 1, radiological intervention was performed tountangle the loop, which was successful.</p><p><strong>Conclusions: </strong>After placing a Swan-Ganz catheter in patients with a pre-existing central venous catheter, the presence of entanglement should be assessed. In such cases, radiology-guided correction is recommended, as a blind attempt to disentangle can aggravate thecondition.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"46-50"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/02/apm-22212.PMC9902637.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9287265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Lymphedema is characterized by localized tissue swelling due to excessive interstitial space retention of lymphatic fluid. Lymphedema is easy to be misdiagnosed since itresembles other conditions of extremity swelling. We present a case of complex regionalpain syndrome (CRPS) type I with secondary lymphedema that was successfully managedwith spinal cord stimulation (SCS).
Case: A 39-year-old female patient came to our pain clinic with complaints of lower extremity pain and edema. To find out reason of leg edema, computed tomography of extremity angiography and blood test were performed. However, all of evaluations were normal. Lastlyperformed lymphoscintigraphy showed secondary lymphedema. SCS was performed and itshowed dramatic reduction subsequent to implantation of SCS.
Conclusions: We could successfully manage the intractable pain and edema in CRPS combined with lymphedema. If a patient presents different nature of edema, coexistence of other disease needs to be considered.
{"title":"Treatment experience in a patient of complex regional pain syndrome combined with secondary lymphedema of lower extremity.","authors":"Ji Hee Hong, Seung Ju Kim","doi":"10.17085/apm.22239","DOIUrl":"https://doi.org/10.17085/apm.22239","url":null,"abstract":"<p><strong>Background: </strong>Lymphedema is characterized by localized tissue swelling due to excessive interstitial space retention of lymphatic fluid. Lymphedema is easy to be misdiagnosed since itresembles other conditions of extremity swelling. We present a case of complex regionalpain syndrome (CRPS) type I with secondary lymphedema that was successfully managedwith spinal cord stimulation (SCS).</p><p><strong>Case: </strong>A 39-year-old female patient came to our pain clinic with complaints of lower extremity pain and edema. To find out reason of leg edema, computed tomography of extremity angiography and blood test were performed. However, all of evaluations were normal. Lastlyperformed lymphoscintigraphy showed secondary lymphedema. SCS was performed and itshowed dramatic reduction subsequent to implantation of SCS.</p><p><strong>Conclusions: </strong>We could successfully manage the intractable pain and edema in CRPS combined with lymphedema. If a patient presents different nature of edema, coexistence of other disease needs to be considered.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"70-74"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/50/apm-22239.PMC9902636.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jihye Park, Su Jin Kim, Hyunho Kim, Haesun Jung, Hwa Yong Shin
Background: Pleurisy is an inflammation of the parietal pleura and is characterized by pleuritic pain. The most common cause of pleurisy is infection; other causes include rheumatoidarthritis, malignancy, rib fractures, or trauma. Possible causes of chest pain associated withgolf include costochondritis, stress fractures of the ribs, intercostal muscle strain, or, rarely,Tietze's syndrome and slipping rib syndrome.
Case: A 64-year-old female presented with intractable chest pain that began 4 months priorwhile playing golf. No specific cause was found after various examinations. There was persistent pain despite medical treatment. Ultrasonography (US) was performed over the painful areas, which revealed focal pleural effusions. A mixture of ropivacaine and triamcinolonewas injected into the focal pleural effusions using US guidance, which dramatically relievedher pain.
Conclusions: This case demonstrates that US can be used as a diagnostic and therapeuticmodality for intractable chest pain with an undetected pathology.
{"title":"Ultrasound diagnosis and treatment of intractable anterior chest pain from golf - A case report.","authors":"Jihye Park, Su Jin Kim, Hyunho Kim, Haesun Jung, Hwa Yong Shin","doi":"10.17085/apm.22182","DOIUrl":"https://doi.org/10.17085/apm.22182","url":null,"abstract":"<p><strong>Background: </strong>Pleurisy is an inflammation of the parietal pleura and is characterized by pleuritic pain. The most common cause of pleurisy is infection; other causes include rheumatoidarthritis, malignancy, rib fractures, or trauma. Possible causes of chest pain associated withgolf include costochondritis, stress fractures of the ribs, intercostal muscle strain, or, rarely,Tietze's syndrome and slipping rib syndrome.</p><p><strong>Case: </strong>A 64-year-old female presented with intractable chest pain that began 4 months priorwhile playing golf. No specific cause was found after various examinations. There was persistent pain despite medical treatment. Ultrasonography (US) was performed over the painful areas, which revealed focal pleural effusions. A mixture of ropivacaine and triamcinolonewas injected into the focal pleural effusions using US guidance, which dramatically relievedher pain.</p><p><strong>Conclusions: </strong>This case demonstrates that US can be used as a diagnostic and therapeuticmodality for intractable chest pain with an undetected pathology.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"65-69"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/91/apm-22182.PMC9902635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Myounghun Kim, Jeonghan Lee, Jinhyeok Kim, Beomseok Choi, Seunghee Ki
Background: Some studies have demonstrated that chemotherapy drugs enhance sensitivity to anesthetics owing to its systemic toxicity, while others have demonstrated that chemotherapy drugs have no effect. This study aimed to determine whether neoadjuvant chemotherapy influences the effect-site concentration (Ce) of propofol for sedation in patients withbreast cancer.
Methods: This study included patients aged 19-75 years who were scheduled to undergobreast cancer surgery under general anesthesia. Patients who received neoadjuvant chemotherapy were assigned to group C, whereas those who never received chemotherapy wereassigned to group N. Propofol was administered through an effect-site target-controlled infusion, and the Modified Observer's Assessment of Alertness/Sedation scale (MOAA/S) scoreand Bispectral Index (BIS) were recorded. When the plasma concentration and Ce wereequal to the target Ce, and if the MOAA/S score did not change, the target Ce was increasedby 0.2 μg/ml; otherwise, the Ce was maintained for 2 min and then increased. This processwas repeated until the MOAA/S score became 0.
Results: No significant differences were observed in Ce values at each sedation level between both groups. Ce values for loss of consciousness (LOC) of groups C and N were 2.76± 0.29 and 2.67 ± 0.27 μg/ml (P = 0.285), respectively. However, the BIS value at LOC ofgroup C (63.87 ± 7.04) was lower than that (68.44 ± 6.01) of group N (P = 0.018).
Conclusions: Neoadjuvant chemotherapy for breast cancer has no effect on the Ce ofpropofol for sedation.
{"title":"Effect of neoadjuvant chemotherapy on effect-site concentration of propofol for sedation in patients with breast cancer.","authors":"Myounghun Kim, Jeonghan Lee, Jinhyeok Kim, Beomseok Choi, Seunghee Ki","doi":"10.17085/apm.22201","DOIUrl":"https://doi.org/10.17085/apm.22201","url":null,"abstract":"<p><strong>Background: </strong>Some studies have demonstrated that chemotherapy drugs enhance sensitivity to anesthetics owing to its systemic toxicity, while others have demonstrated that chemotherapy drugs have no effect. This study aimed to determine whether neoadjuvant chemotherapy influences the effect-site concentration (Ce) of propofol for sedation in patients withbreast cancer.</p><p><strong>Methods: </strong>This study included patients aged 19-75 years who were scheduled to undergobreast cancer surgery under general anesthesia. Patients who received neoadjuvant chemotherapy were assigned to group C, whereas those who never received chemotherapy wereassigned to group N. Propofol was administered through an effect-site target-controlled infusion, and the Modified Observer's Assessment of Alertness/Sedation scale (MOAA/S) scoreand Bispectral Index (BIS) were recorded. When the plasma concentration and Ce wereequal to the target Ce, and if the MOAA/S score did not change, the target Ce was increasedby 0.2 μg/ml; otherwise, the Ce was maintained for 2 min and then increased. This processwas repeated until the MOAA/S score became 0.</p><p><strong>Results: </strong>No significant differences were observed in Ce values at each sedation level between both groups. Ce values for loss of consciousness (LOC) of groups C and N were 2.76± 0.29 and 2.67 ± 0.27 μg/ml (P = 0.285), respectively. However, the BIS value at LOC ofgroup C (63.87 ± 7.04) was lower than that (68.44 ± 6.01) of group N (P = 0.018).</p><p><strong>Conclusions: </strong>Neoadjuvant chemotherapy for breast cancer has no effect on the Ce ofpropofol for sedation.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"29-36"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/9e/apm-22201.PMC9902627.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9286845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2022-10-26DOI: 10.17085/apm.22215
Seyeon Park, Sang-Wook Shin, Hye-Jin Kim, Gyeong-Jo Byeon, Ji-Uk Yoon, Eun-Jung Kim, Hee Young Kim
Selection and insertion of an endotracheal tube (ETT) of appropriate size for airway management during general anesthesia in pediatric patients is very important. A very small ETT increases the risk of inadequate ventilation, air leakage, and aspiration, whereas a very large ETT may cause serious complications including airway damage, post-intubation croup, and, in severe cases, subglottic stenosis. Although the pediatric larynx is conical, the narrowest part, the rima glottidis, is cylindrical in the anteroposterior dimension, regardless of development, and the cricoid ring is slightly elliptical. A cuffed ETT reduces the number of endotracheal intubation attempts, and if cuff pressure can be maintained within a safe range, the risk of airway damage may not be greater than that of an ETT without cuff. The age-based formula suggested by Cole (age/4 + 4) has long been used to select the appropriate ETT size in children. Because age-based formulas in children are not always accurate, various alternative methods for estimating the ETT size have been examined and suggested. Chest radiography, ultrasound, and a three-dimensional airway model can be used to determine the appropriate ETT size; however, there are several limitations.
在对儿科患者进行全身麻醉时,选择和插入大小合适的气管导管(ETT)以进行气道管理非常重要。过小的 ETT 会增加通气不足、漏气和吸入的风险,而过大的 ETT 则可能导致严重的并发症,包括气道损伤、插管后气管痉挛,严重时还会导致声门下狭窄。虽然小儿喉部呈圆锥形,但其最狭窄的部分(声门区)在前后维度上呈圆柱形,与发育情况无关,环甲膜环则略呈椭圆形。带充气罩囊的 ETT 可减少气管插管的次数,如果充气罩囊压力能保持在安全范围内,气道损伤的风险可能并不比不带充气罩囊的 ETT 大。长期以来,Cole 提出的基于年龄的公式(年龄/4 + 4)一直被用于为儿童选择合适的 ETT 大小。由于以儿童年龄为基础的公式并不总是准确的,因此人们研究并提出了各种估算 ETT 大小的替代方法。胸片、超声波和三维气道模型可用于确定合适的 ETT 大小;但这些方法都有一些局限性。
{"title":"Choice of the correct size of endotracheal tube in pediatric patients.","authors":"Seyeon Park, Sang-Wook Shin, Hye-Jin Kim, Gyeong-Jo Byeon, Ji-Uk Yoon, Eun-Jung Kim, Hee Young Kim","doi":"10.17085/apm.22215","DOIUrl":"10.17085/apm.22215","url":null,"abstract":"<p><p>Selection and insertion of an endotracheal tube (ETT) of appropriate size for airway management during general anesthesia in pediatric patients is very important. A very small ETT increases the risk of inadequate ventilation, air leakage, and aspiration, whereas a very large ETT may cause serious complications including airway damage, post-intubation croup, and, in severe cases, subglottic stenosis. Although the pediatric larynx is conical, the narrowest part, the rima glottidis, is cylindrical in the anteroposterior dimension, regardless of development, and the cricoid ring is slightly elliptical. A cuffed ETT reduces the number of endotracheal intubation attempts, and if cuff pressure can be maintained within a safe range, the risk of airway damage may not be greater than that of an ETT without cuff. The age-based formula suggested by Cole (age/4 + 4) has long been used to select the appropriate ETT size in children. Because age-based formulas in children are not always accurate, various alternative methods for estimating the ETT size have been examined and suggested. Chest radiography, ultrasound, and a three-dimensional airway model can be used to determine the appropriate ETT size; however, there are several limitations.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"352-360"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/3c/apm-22215.PMC9663958.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2022-10-19DOI: 10.17085/apm.22189
Sanghoon Song, Ho Bum Cho, Sun Young Park, Wan Mo Koo, Sang Jin Choi, Sokyung Yoon, Suyeon Park, Jae Hwa Yoo, Mun Gyu Kim, Ji Won Chung, Sang Ho Kim
Background: Clearance of the sugammadex-rocuronium complex is limited to renal excretion. There are restrictions on the use of sugammadex in patients with severe renal impairment. A paucity of data supports the clinical safety of sugammadex in patients with renal impairment. We analyzed mortality after using sugammadex in patients with end-stage renal disease to establish evidence of safety for sugammadex.
Methods: We retrospectively collected the medical records of 2,134 patients with end-stage renal disease who were dependent on hemodialysis and underwent surgery under general anesthesia between January 2018 and December 2019. Propensity score matching was used. The primary outcome was the 30-day mortality rate, and secondary outcomes were the 1-year mortality rate and causes of death.
Results: A total of 2,039 patients were included in the study. Sugammadex was administered as a reversal agent for rocuronium in 806 (39.5%) patients; the remaining 1,233 (60.5%) patients did not receive sugammadex. After matching, 1,594 patients were analyzed; 28 (3.5%) of the 797 patients administered sugammadex, and 28 (3.5%) of the 797 patients without sugammadex, died within 30 days after surgery (P > 0.99); 38 (4.8%) of the 797 patients administered sugammadex, and 45 (5.7%) of the 797 patients without sugammadex, died within 1 year after surgery (P = 0.499). No significant differences in the causes of 30-day mortality were observed between the two groups after matching (P = 0.860).
Conclusions: In this retrospective study, sugammadex did not increase the 30-day and 1-year mortality rate after surgery in end-stage renal disease patients.
{"title":"Postoperative mortality in patients with end-stage renal disease according to the use of sugammadex: a single-center retrospective propensity score matched study.","authors":"Sanghoon Song, Ho Bum Cho, Sun Young Park, Wan Mo Koo, Sang Jin Choi, Sokyung Yoon, Suyeon Park, Jae Hwa Yoo, Mun Gyu Kim, Ji Won Chung, Sang Ho Kim","doi":"10.17085/apm.22189","DOIUrl":"https://doi.org/10.17085/apm.22189","url":null,"abstract":"<p><strong>Background: </strong>Clearance of the sugammadex-rocuronium complex is limited to renal excretion. There are restrictions on the use of sugammadex in patients with severe renal impairment. A paucity of data supports the clinical safety of sugammadex in patients with renal impairment. We analyzed mortality after using sugammadex in patients with end-stage renal disease to establish evidence of safety for sugammadex.</p><p><strong>Methods: </strong>We retrospectively collected the medical records of 2,134 patients with end-stage renal disease who were dependent on hemodialysis and underwent surgery under general anesthesia between January 2018 and December 2019. Propensity score matching was used. The primary outcome was the 30-day mortality rate, and secondary outcomes were the 1-year mortality rate and causes of death.</p><p><strong>Results: </strong>A total of 2,039 patients were included in the study. Sugammadex was administered as a reversal agent for rocuronium in 806 (39.5%) patients; the remaining 1,233 (60.5%) patients did not receive sugammadex. After matching, 1,594 patients were analyzed; 28 (3.5%) of the 797 patients administered sugammadex, and 28 (3.5%) of the 797 patients without sugammadex, died within 30 days after surgery (P > 0.99); 38 (4.8%) of the 797 patients administered sugammadex, and 45 (5.7%) of the 797 patients without sugammadex, died within 1 year after surgery (P = 0.499). No significant differences in the causes of 30-day mortality were observed between the two groups after matching (P = 0.860).</p><p><strong>Conclusions: </strong>In this retrospective study, sugammadex did not increase the 30-day and 1-year mortality rate after surgery in end-stage renal disease patients.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"371-380"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/20/apm-22189.PMC9663945.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2022-10-19DOI: 10.17085/apm.22170
Haesoo Kim, Jeongyoon Lee, Sang-Gon Lee, Kwang-Seok Shim
Background: Due to its various advantages, laparoscopic surgery is preferred over laparotomy in patients who require hepatic resection. Carbon dioxide embolism -which occurs approximately ten times more often in laparoscopic hepatectomy than in general laparoscopic surgery-presents with insignificant symptoms and may be overlooked.
Case: A 70-year-old male with hepatic cell carcinoma underwent laparoscopic hepatectomy. Though his vital signs were stable during the initiation of surgery, they became unstable during the procedure. The surgeon detected portal vein rupture, and transesophageal echocardiography was subsequently performed. A large amount of gas in the heart chamber and paradoxical embolism through a patent foramen ovale due to a right-to-left shunt were observed. We treated the symptoms, and the surgery was completed without any further issues.
Conclusions: Active use of transesophageal echocardiography to identify and monitor heart functions during a suspected carbon dioxide embolism can significantly reduce morbidity and mortality associated with that embolism.
{"title":"Detection of paradoxical carbon dioxide gas embolism with opening of patent foramen ovale by perioperative transesophageal echocardiography during laparoscopic hepatectomy - A case report.","authors":"Haesoo Kim, Jeongyoon Lee, Sang-Gon Lee, Kwang-Seok Shim","doi":"10.17085/apm.22170","DOIUrl":"https://doi.org/10.17085/apm.22170","url":null,"abstract":"<p><strong>Background: </strong>Due to its various advantages, laparoscopic surgery is preferred over laparotomy in patients who require hepatic resection. Carbon dioxide embolism -which occurs approximately ten times more often in laparoscopic hepatectomy than in general laparoscopic surgery-presents with insignificant symptoms and may be overlooked.</p><p><strong>Case: </strong>A 70-year-old male with hepatic cell carcinoma underwent laparoscopic hepatectomy. Though his vital signs were stable during the initiation of surgery, they became unstable during the procedure. The surgeon detected portal vein rupture, and transesophageal echocardiography was subsequently performed. A large amount of gas in the heart chamber and paradoxical embolism through a patent foramen ovale due to a right-to-left shunt were observed. We treated the symptoms, and the surgery was completed without any further issues.</p><p><strong>Conclusions: </strong>Active use of transesophageal echocardiography to identify and monitor heart functions during a suspected carbon dioxide embolism can significantly reduce morbidity and mortality associated with that embolism.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"397-403"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/31/apm-22170.PMC9663957.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2022-10-06DOI: 10.17085/apm.21120
Minsoo Kim, Daehun Goh, Soyeon Cho, Yeonji Noh, Byeongmun Hwang
Background: Long thoracic nerve (LTN) neuropathy occasionally occurs in young people who engage in various sports. It may have a traumatic or non-traumatic etiology. The landmark manifestation of LTN neuropathy is scapular winging; however, it can also occur without scapular winging and specific magnetic resonance imaging findings.
Case: An 18-year-old male complained of right-sided lateral chest pain for 7 months. He was treated with medication, trigger point injection, and physical therapy but showed no improvement. Electromyelogram findings suggested LTN neuropathy in the right lateral chest. We performed a serratus anterior (SA) plane block with ultrasound (US)-guided hydrodissection and achieved pain relief.
Conclusions: We report the successful treatment of LTN neuropathy with an SA plane block and US-guided hydrodissection.
{"title":"Serratus anterior plane block with ultrasound-guided hydrodissection for lateral thoracic pain caused by long thoracic nerve neuropathy - A case report.","authors":"Minsoo Kim, Daehun Goh, Soyeon Cho, Yeonji Noh, Byeongmun Hwang","doi":"10.17085/apm.21120","DOIUrl":"https://doi.org/10.17085/apm.21120","url":null,"abstract":"<p><strong>Background: </strong>Long thoracic nerve (LTN) neuropathy occasionally occurs in young people who engage in various sports. It may have a traumatic or non-traumatic etiology. The landmark manifestation of LTN neuropathy is scapular winging; however, it can also occur without scapular winging and specific magnetic resonance imaging findings.</p><p><strong>Case: </strong>An 18-year-old male complained of right-sided lateral chest pain for 7 months. He was treated with medication, trigger point injection, and physical therapy but showed no improvement. Electromyelogram findings suggested LTN neuropathy in the right lateral chest. We performed a serratus anterior (SA) plane block with ultrasound (US)-guided hydrodissection and achieved pain relief.</p><p><strong>Conclusions: </strong>We report the successful treatment of LTN neuropathy with an SA plane block and US-guided hydrodissection.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"434-438"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/b7/apm-21120.PMC9663951.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
by Joung et al. [1] published in Anesthesia & Pain Medicine. We wish to describe our experience with different anesthetic drugs and techniques in a patient with catatonia undergoing multiple electroconvulsive therapy (ECT) sessions. Catatonia is characterized by a constellation of psychomotor disturbances associated with immobility, mutism, and rigidity [2]. ECT is the preferred treatment modality [2]. As patients with catatonia are prone to muscle rigidity, hyperkalemia, and deteriorating Glasgow coma scale (GCS) score, anesthesia is challenging for ECT procedures [3]. A 48-year-old female patient weighing 35 kg presented with hallucinations, dementia, and increased muscle rigidity in all four limbs for the past 6 months and was diagnosed with catatonia (secondary to Lewy bodies in the substantia nigra). As the patient was resistant to pharmacological therapy (lorazepam, escitalopram, and syndopa), ECT was finally planned. Her GCS score was E4V1M5. As routine blood investigations were normal, our main concern was serum potassium (4.45 mEq/L), which was expected to rise further with succinylcholine, a commonly used neuromuscular blocking drug (NMBD) in ECT procedures [2]. In her first ECT session, succinylcholine was avoided because of the reported risk of life-threatening hyperkalemia as a result of upregulation of nicotinic cholinergic receptors secondary to long-term immobilization (as the patient was immobilized for the past 6 months). Glycopyrrolate (0.2 mg), propofol (80 mg), and atracurium (15 mg) were administered to the patient. I-gel insertion and propofol infusion were started for maintenance until recovery from neuromuscular blockade. After the procedure, the patient recovered to her preoperative GCS score. In the second ECT session, the same anesthesia technique was used. There was no improvement in the GCS score after two ECT sessions although an improvement in muscle rigidity was observed. In the third ECT session, it was decided to use succinylcholine instead of atracurium with complete preparation for monitoring, diagnosis, and management of hyperkalemia, in case Letter to the Editor Anesth Pain Med 2022;17:454-455 https://doi.org/10.17085/apm.22202 pISSN 1975-5171 • eISSN 2383-7977
{"title":"Electroconvulsive therapy in a catatonia patient: succinylcholine or no succinylcholine?","authors":"Manbir Kaur, Swati Chhabra, Pradeep Bhatia, Ravindra Singh Chouhan","doi":"10.17085/apm.22202","DOIUrl":"https://doi.org/10.17085/apm.22202","url":null,"abstract":"by Joung et al. [1] published in Anesthesia & Pain Medicine. We wish to describe our experience with different anesthetic drugs and techniques in a patient with catatonia undergoing multiple electroconvulsive therapy (ECT) sessions. Catatonia is characterized by a constellation of psychomotor disturbances associated with immobility, mutism, and rigidity [2]. ECT is the preferred treatment modality [2]. As patients with catatonia are prone to muscle rigidity, hyperkalemia, and deteriorating Glasgow coma scale (GCS) score, anesthesia is challenging for ECT procedures [3]. A 48-year-old female patient weighing 35 kg presented with hallucinations, dementia, and increased muscle rigidity in all four limbs for the past 6 months and was diagnosed with catatonia (secondary to Lewy bodies in the substantia nigra). As the patient was resistant to pharmacological therapy (lorazepam, escitalopram, and syndopa), ECT was finally planned. Her GCS score was E4V1M5. As routine blood investigations were normal, our main concern was serum potassium (4.45 mEq/L), which was expected to rise further with succinylcholine, a commonly used neuromuscular blocking drug (NMBD) in ECT procedures [2]. In her first ECT session, succinylcholine was avoided because of the reported risk of life-threatening hyperkalemia as a result of upregulation of nicotinic cholinergic receptors secondary to long-term immobilization (as the patient was immobilized for the past 6 months). Glycopyrrolate (0.2 mg), propofol (80 mg), and atracurium (15 mg) were administered to the patient. I-gel insertion and propofol infusion were started for maintenance until recovery from neuromuscular blockade. After the procedure, the patient recovered to her preoperative GCS score. In the second ECT session, the same anesthesia technique was used. There was no improvement in the GCS score after two ECT sessions although an improvement in muscle rigidity was observed. In the third ECT session, it was decided to use succinylcholine instead of atracurium with complete preparation for monitoring, diagnosis, and management of hyperkalemia, in case Letter to the Editor Anesth Pain Med 2022;17:454-455 https://doi.org/10.17085/apm.22202 pISSN 1975-5171 • eISSN 2383-7977","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"454-455"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9e/34/apm-22202.PMC9663952.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}